Our Pricing

Mounjaro Medicine - Lowest Price UK from £124.99

Published on: June 03, 2026

When searching for mounjaro medicine lowest price uk, Cured Pharmacy offers genuine UK-licensed Mounjaro (tirzepatide) pens from £124.99 with transparent upfront pricing and free clinical consultations. Our UK-registered clinical team provides expert assessment in under three minutes, ensuring you receive safe, effective treatment at the lowest guaranteed price in the UK.

How Mounjaro Medicine Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced effects on appetite regulation, insulin secretion, and energy expenditure.

In the landmark SURPASS-3 clinical trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly greater than comparator treatments [1]. The dual mechanism helps reduce hunger signals from the brain whilst slowing gastric emptying, allowing patients to feel satisfied with smaller portions and maintain consistent energy levels throughout the day.

Mounjaro is administered as a once-weekly subcutaneous injection using the convenient KwikPen device. The treatment follows a gradual dose escalation schedule, typically starting at 2.5mg and increasing every four weeks as tolerated, allowing your body to adapt and minimising potential side effects. All dosing decisions are made by your UK prescriber based on your individual response and tolerability.

Mounjaro Medicine Lowest Price UK: Transparent Pricing at Cured Pharmacy

At Cured Pharmacy, we believe in complete pricing transparency. Our Mounjaro medicine starts from £124.99, with the exact cost determined by your prescribed dose following clinical assessment by a UK-registered prescriber. Unlike some providers who hide prices until after consultation, we display all costs upfront so you can make informed decisions about your weight management journey.

The price you see includes your genuine UK-licensed Mounjaro KwikPen, free clinical consultation with our expert prescribers, and discreet delivery to your door. There are no hidden fees, no subscription traps, and no pressure to commit before you're ready. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) personally oversees every prescription to ensure clinical safety and regulatory compliance.

We guarantee the lowest prices in the UK for genuine Mounjaro medicine. If you find a lower price from another UK-registered pharmacy for the same dose, we'll match it. Our commitment to affordability ensures that effective weight management remains accessible to patients across the country, without compromising on clinical quality or pharmaceutical standards.

What's Included in Your Mounjaro Price

Your Mounjaro treatment package includes a comprehensive clinical consultation with a UK-registered prescriber who will review your medical history, current medications, and weight management goals. Once approved, you'll receive genuine UK-licensed Mounjaro KwikPens manufactured by Eli Lilly, complete with detailed administration instructions and ongoing support from our pharmacy team.

We also provide discreet packaging with next-day delivery options, ensuring your medication arrives safely and privately. Our clinical team remains available throughout your treatment for any questions about dosing, side effects, or progress monitoring. This complete care package is included in our transparent pricing structure, with no additional consultation fees or hidden charges.

Clinical Evidence: Mounjaro vs Other Weight Loss Treatments

Head-to-head clinical trials demonstrate Mounjaro's superior efficacy compared to other licensed weight loss medications. In the SURPASS-2 trial, tirzepatide 15mg produced an average weight reduction of 12.4kg compared to 6.2kg with semaglutide 1mg over 40 weeks [2]. This represents nearly double the weight loss, though individual results vary based on adherence, lifestyle factors, and metabolic response.

The STEP programme trials established semaglutide's efficacy, with participants achieving average weight reductions of 14.9% over 68 weeks on the 2.4mg dose [3]. Whilst this represents significant clinical benefit, tirzepatide's dual-receptor mechanism consistently demonstrates enhanced outcomes across multiple trials. Both medications require commitment to dietary modifications and increased physical activity to achieve optimal results.

Liraglutide, marketed as Saxenda, was the first GLP-1 receptor agonist licensed for weight management in the UK. Clinical trials showed average weight loss of 8% over 56 weeks [4]. Whilst effective, the daily injection requirement and lower magnitude of weight reduction make it less suitable for patients seeking maximum efficacy. Your UK prescriber will help determine which treatment aligns best with your clinical profile and personal preferences.

Understanding Your Treatment Options

Choosing between Mounjaro, Wegovy, and Saxenda depends on multiple factors including your weight loss goals, injection frequency preference, previous treatment experience, and budget considerations. Mounjaro offers the highest average weight reduction in clinical trials but requires weekly injections and represents a higher investment. Wegovy provides substantial weight loss with once-weekly dosing at a lower price point, whilst Saxenda offers daily dosing flexibility for patients who prefer more frequent, lower-dose administration.

Our UK prescribers conduct thorough assessments to recommend the most appropriate treatment for your circumstances. This includes reviewing your BMI, weight-related health conditions, previous weight loss attempts, current medications, and any contraindications. The consultation process ensures you receive safe, effective treatment tailored to your individual needs rather than a one-size-fits-all approach.

Starting Mounjaro Treatment: The Clinical Assessment Process

All Mounjaro prescriptions at Cured Pharmacy begin with a comprehensive online clinical assessment conducted by UK-registered prescribers. The consultation takes under three minutes to complete and covers your medical history, current medications, weight management history, and treatment goals. This ensures Mounjaro is clinically appropriate and safe for your individual circumstances.

Your prescriber will assess whether you meet the NICE criteria for prescription weight management medication, typically requiring a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related health conditions such as type 2 diabetes, hypertension, or dyslipidaemia. They'll also review potential contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease.

Once approved, your prescription is sent electronically to our UK-registered pharmacy (GPhC 9012511) where it's clinically checked and dispensed by our expert team. Your Mounjaro KwikPens are then dispatched in discreet packaging with tracked delivery. You'll receive detailed administration instructions, dosing schedules, and direct contact information for our pharmacy team should you need support during your treatment journey.

Mounjaro Side Effects and Safety Considerations

Like all GLP-1 receptor agonists, Mounjaro may cause gastrointestinal side effects, particularly during the initial dose escalation phase. The most commonly reported effects include nausea, diarrhoea, decreased appetite, vomiting, constipation, and abdominal discomfort [1]. These effects typically diminish over 4-8 weeks as your body adapts to the medication, and the gradual dose escalation protocol minimises their severity.

More serious but rare side effects include pancreatitis, gallbladder problems, and hypoglycaemia (particularly in patients taking other diabetes medications). You should contact your prescriber immediately if you experience severe abdominal pain, persistent vomiting, or signs of allergic reaction. The MHRA maintains active pharmacovigilance for all GLP-1 medications, and any suspected side effects should be reported through the Yellow Card scheme.

Mounjaro is contraindicated in pregnancy and breastfeeding. Women of childbearing potential should use effective contraception during treatment and for at least two months after discontinuation. If you're planning pregnancy, discuss alternative weight management strategies with your prescriber. Regular monitoring of your weight, blood pressure, and metabolic parameters helps ensure treatment remains safe and effective throughout your weight loss journey.

Managing Side Effects Effectively

Most patients find that gastrointestinal side effects can be managed through simple dietary modifications. Eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and reducing portion sizes helps minimise nausea and digestive discomfort. Our pharmacy team provides detailed guidance on dietary strategies that complement your Mounjaro treatment and support sustainable weight loss.

If side effects persist or become troublesome, your prescriber may recommend remaining at your current dose for an additional month before escalating, or adjusting the titration schedule to improve tolerability. The goal is to reach the most effective dose that you can tolerate comfortably, balancing clinical efficacy with quality of life throughout your treatment programme.

Maximising Your Results: Lifestyle Support with Mounjaro

Whilst Mounjaro produces significant weight loss through its pharmacological effects, optimal results require commitment to sustainable lifestyle modifications. Clinical trials included structured dietary counselling and physical activity recommendations, contributing to the impressive outcomes reported [1]. The medication works best when combined with a reduced-calorie diet and increased physical activity tailored to your current fitness level.

Focus on incorporating whole foods, lean proteins, vegetables, and complex carbohydrates whilst minimising processed foods, added sugars, and excessive fats. The appetite-suppressing effects of Mounjaro make it easier to adhere to these dietary changes, but conscious food choices remain essential. Many patients find that meal planning, portion control strategies, and mindful eating practices help maintain consistency and prevent old habits from returning.

Regular physical activity enhances weight loss, preserves lean muscle mass, and improves metabolic health markers. Start with achievable goals such as 150 minutes of moderate-intensity activity per week, gradually increasing as your fitness improves and weight reduces. Activities like brisk walking, swimming, cycling, or resistance training all contribute to sustainable results. Our clinical team can provide guidance on setting realistic goals and tracking progress throughout your treatment journey.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment, dietary modifications, and physical activity levels.